The therapeutic effect is achieved by reducing FA and cholesterol synthesis through the inhibition of ACLY (143)
For a post-bariatric patient, it is not
India Demand for GLP-1 receptor agonists in India is projected to rise at 8.4% CAGR through 2036
GLP-1 drugs have been shown to be effective for weight loss, though they come with a number of side effects for some patients, including nausea, vomiting, headaches, diarrhea, and constipation, according to Harvard Medical School and the Cleveland Clinic
These findings are consistent with data accessed October 10, 2025
Ozempic is one of several GLP-1 agonists, a class of medication created to treat type 2 diabetes, but has also been shown to help with weight loss